About this trial
This prospective randomized study will compare the effects of Erector Spinae Plane Block (ESPB) and Serratus Anterior Plane Block combined with Pectoral Nerve Block Type II (SAPB + PECS II) on intraoperative analgesia and postoperative opioid consumption in patients undergoing breast cancer surgery. Seventy patients (ASA I-III, aged 18-75 years) will be randomized into two groups using the sealed envelope method. Ultrasound-guided blocks will be performed preoperatively by the same anesthesiologist, with Group 1 receiving ESPB and Group 2 receiving a combined SAPB + PECS II technique performed through a single skin puncture (single needle entry site) with sequential injections into the two target fascial planes. All patients will undergo surgery under general anesthesia and receive postoperative analgesia via morphine patient-controlled analgesia. Pain scores and total opioid consumption will be statistically analyzed, with p \< 0.05 considered significant.
Eligibility criteria
Qualifiers
Age between 18 and 75 years
ASA physical status I-III
No history of bleeding or coagulation disorders
Absence of neuropathy
Disqualifiers
systemic or regional infection
known allergy to local anesthetics
Unwillingness to participate in the study
Trial design
Treatments tested in this trial
- SAPB + PECS II Technique
- Erector Spinae Plane Block